drug discovery
The firm has revamped its business model to focus on AI-driven drug discovery and partnerships with pharma and academic cancer researchers.
Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D
Data analysis firm Syntegra will work with NashBio to produce and validate synthetic data from the BioVU biobank, starting with type 2 diabetes.
ERS Genomics Licenses CRISPR Patents to Nuvisan
Nuvisan, based in Waltrop, Germany, will use ERS'w Genomics CRISPR-Cas9 portfolio to help advance its clients' drug discovery and early development programs.
Enpicom, Viroclinics-DDL Expand Partnership to Accelerate Antibody, Vaccine Discovery
A Dutch province has awarded an unspecified sum to the Netherlands-based firms to combine their technologies for TCR and BCR repertoire sequencing and analysis.
Cleveland Clinic, IBM Partner on High-Performance Computing for Life Science, Healthcare Research
Under their 10-year partnership, IBM will install an early instance of its Quantum System One at Cleveland Clinic to promote AI-driven life sciences discovery.